SCHEMBL13685352

SCHEMBL13685352

NCc1ccc(-c2csc(NCC3CC3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.45
MAPT P10636 8/20 0.45
KMT2A Q03164 7/20 0.45
RAB9A P51151 7/20 0.45
MEN1 O00255 6/20 0.45
NPC1 O15118 6/20 0.45
ALDH1A1 P00352 5/20 0.45
LMNA P02545 3/20 0.45
ALOX15 P16050 1/20 0.45
ALOX12 P18054 1/20 0.45
HSD17B10 Q99714 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
NFKB1 P19838 1/20 0.42
CYP2C19 P33261 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2584637 0.95 NPC1 (0.44) NPY5RMAPTKMT2ARAB9AMEN1
SCHEMBL2581890 0.94 NPC1 (0.46) NPY5RMAPTKMT2ARAB9AMEN1
SCHEMBL2255388 0.83 MAPT (0.60) NPY5RMAPTKMT2ARAB9AMEN1
SCHEMBL2580010 0.83 CCNK (0.44) NPY5RCCNKCDK9
SCHEMBL2585031 0.82 CCNK (0.43) NPY5RMAPTKMT2ARAB9AMEN1
SCHEMBL13685290 0.80 KMT2A (0.68) MAPTKMT2ARAB9AMEN1NPC1
SCHEMBL5131839 0.80 CCNK (0.50) NPY5RMAPTKMT2ARAB9AMEN1
SCHEMBL1473954 0.79 CSNK2A1 (0.54) NPY5RMAPTKMT2ARAB9AMEN1
SCHEMBL13685439 0.78 RAB9A (0.57) MAPTKMT2ARAB9AMEN1NPC1
SCHEMBL13685464 0.78 RAB9A (0.50) MAPTKMT2ARAB9AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101258131-B As 5-HT2c6-aralkylamino-2 receptor agonists LILLY CO ELI 2013-07-24 CN disclosed
EP-1924561-B1 6-ARYLALKYLAMINO- 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS LILLY CO ELI (US) 2012-11-14 EP disclosed